Microbial Crosstalk with Therapy: Pharmacomicrobiomics in AML—One Step Closer to Personalized Medicine
Increasing evidence demonstrates the mutualistic connection between the microbiome and acute myeloid leukemia (AML) treatment. Drugs disrupt the microbial balance and, conversely, changes in the microbiome influence therapy. A new field, pharmacomicrobiomics, examines the role of the microbiome in p...
Saved in:
| Main Authors: | Aneta Nowicka, Hanna Tomczak, Edyta Szałek, Agnieszka Karbownik, Lidia Gil |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1761 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of pharmacomicrobiomics in HIV prevention, treatment, and women’s health
by: Erik C. Swanson, et al.
Published: (2024-12-01) -
Healthy gut microbiomes are host-controllable microbiomes
by: Théodore Bouchez, et al.
Published: (2025-01-01) -
Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung–Gut Axis and Beyond
by: Md Habibul Hasan Mazumder, et al.
Published: (2024-10-01) -
Editorial: Advances in the microbiome, immunity and cancer interplay
by: Gratiela Gradisteanu Pircalabioru, et al.
Published: (2025-03-01) -
The Relationship of Dysbiosis of Duodenal Microbiome and Functional Dyspepsia
by: Nayoung Kim
Published: (2024-12-01)